DaVita

DaVita

A leading provider of kidney care. Learn more

Launch date
Employees
Market cap
€12.0b
Enterprise valuation
€22.2b (Public information from Sep 2024)
Denver Colorado (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
USD2020202120222023202420252026
Revenues11.6b11.6b11.6b12.1b12.7b13.3b13.7b
% growth1 %1 %-5 %5 %4 %3 %
EBITDA2.4b2.5b2.1b2.4b2.7b2.8b2.9b
% EBITDA margin20 %21 %18 %19 %21 %21 %21 %
Profit774m978m560m692m809m847m705m
% profit margin7 %8 %5 %6 %6 %6 %5 %
EV / revenue1.8x1.7x1.3x1.4x1.8x1.7x1.7x
EV / EBITDA8.9x8.0x7.5x7.4x8.6x8.3x8.1x
  • Edit
DateInvestorsAmountRound

N/A

Growth Equity VC
N/A

N/A

IPO
*
N/A

$750m

Post IPO Debt
Total Funding-

Recent News about DaVita

Edit
More about DaVitainfo icon
Edit

DaVita is a healthcare company specializing in providing comprehensive kidney care services. It primarily serves patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD), focusing on delivering value-based care. Operating in the healthcare market, DaVita offers a range of services including dialysis treatment, kidney health education, and dietary guidance. The company generates revenue through its network of dialysis centers and integrated care programs, which are designed to improve patient outcomes and reduce healthcare costs. DaVita's business model revolves around patient-centric care, leveraging clinical metrics to track and enhance treatment efficacy. The company also provides educational resources such as Kidney Smart classes and risk quizzes to help patients manage their kidney health proactively. By focusing on holistic and equitable care, DaVita aims to transform the kidney care landscape and build a robust healthcare community.

Keywords: kidney care, dialysis, chronic kidney disease, end-stage renal disease, value-based care, patient-centric, healthcare, integrated care, dietary guidance, clinical metrics.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by DaVita

Edit
Renal Services
ACQUISITION by DaVita Feb 2021
MedSleuth
ACQUISITION by DaVita Jan 2022